Getting your player ready...
Boulder-based OPX Biotechnologies Inc. recently raised $36.5 million, funds that officials say will be crucial toward the demonstration and eventual commercialization of bioacrylic products, the Daily Camera reported Wednesday.
In a regulatory filing made Tuesday, OPX officials disclosed that they raised about $36.5 million out of a total offering amount of nearly $45 million. Six investors provided the funding, according to the Securities and Exchange Commission filing.
